UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 931

Sortiert nach

Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia

Journal of clinical oncology, 2010-02, Vol.28 (4), p.562-569

2010

Volltextzugriff (PDF)

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

The New England journal of medicine, 2020-12, Vol.383 (26), p.2526-2537

2020

Volltextzugriff (PDF)

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3322-3327

2011

Volltextzugriff (PDF)

Further Analysis of Trials With Azacitidine in Patients With Myelodysplastic Syndrome: Studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3895-3903

2006

Volltextzugriff (PDF)

Azacitidine improves clinical outcomes in older patients with acute myeloid leukaemia with myelodysplasia-related changes compared with conventional care regimens

BMC cancer, 2017-12, Vol.17 (1), p.852-852, Article 852

2017

Volltextzugriff (PDF)

Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis

Journal of clinical oncology, 2013-07, Vol.31 (21), p.2662-2670

2013

Volltextzugriff (PDF)

Hematologic Response to Three Alternative Dosing Schedules of Azacitidine in Patients With Myelodysplastic Syndromes

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1850-1856

2009

Volltextzugriff (PDF)

Randomized study of continuous high-dose lenalidomide, sequential azacitidine and lenalidomide, or azacitidine in persons 65 years and over with newly-diagnosed acute myeloid leukemia

Haematologica (Roma), 2018-01, Vol.103 (1), p.101

2018

Volltextzugriff (PDF)

Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

Critical reviews in oncology/hematology, 2010-12, Vol.76 (3), p.218-227

2010

Volltextzugriff (PDF)

Oral Azacitidine (CC-486) for the Treatment of Myeloid Malignancies

Clinical lymphoma, myeloma and leukemia, 2022-04, Vol.22 (4), p.236-250

2022

Volltextzugriff (PDF)

Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1475-1483

2020

Volltextzugriff (PDF)

Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels

Leukemia & lymphoma, 2020-05, Vol.61 (6), p.1475-1483

2020

Volltextzugriff (PDF)

Impact of Lenalidomide Treatment on Overall Survival in Patients With Lower-Risk, Transfusion-Dependent Myelodysplastic Syndromes

Clinical lymphoma, myeloma and leukemia, 2022-09, Vol.22 (9), p.e874-e883

2022

Volltextzugriff (PDF)

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial

Journal of hematology and oncology, 2021-08, Vol.14 (1), p.1-133, Article 133

2021

Volltextzugriff (PDF)

CC-486 (oral azacitidine) in patients with myelodysplastic syndromes with pretreatment thrombocytopenia

Leukemia research, 2018-09, Vol.72, p.79-85

2018

Volltextzugriff (PDF)

Oral azacitidine prolongs survival of patients with AML in remission independently of measurable residual disease status

Blood, 2022-04, Vol.139 (14), p.2145-2155

2022

Volltextzugriff (PDF)

Population Pharmacokinetics of Oral Azacitidine, and Exposure–Response Analysis in Acute Myeloid Leukemia

Clinical pharmacology and therapeutics, 2023-10, Vol.114 (4), p.845-852

2023

Volltextzugriff (PDF)

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

Journal of clinical oncology, 2016-09, Vol.34 (25), p.2988-2996

2016

Volltextzugriff (PDF)

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Leukemia, 2018-12, Vol.32 (12), p.2546-2557

2018

Volltextzugriff (PDF)

Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine

Blood, 2022-10, Vol.140 (15), p.1674-1685

2022

Volltextzugriff (PDF)

Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1426-1436

2021

Volltextzugriff (PDF)

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies

Clinical pharmacokinetics, 2020-02, Vol.59 (2), p.217-227

2020

Volltextzugriff (PDF)

1 – 25 von 931

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(798)
Mit Volltextzugriff
(794)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(561)
Life Sciences & Biomedicine
(456)
Humans
(373)
Female
(218)
Male
(203)
Biological And Medical Sciences
(179)
Medical Sciences
(140)
Aged
(139)
Middle Aged
(133)
Adult
(111)
Physical Sciences
(83)
Animals
(79)
Aged, 80 And Over
(67)
Neurosciences & Neurology
(63)
Neurosciences
(50)
Oncology
(49)
Fundamental And Applied Biological Sciences. Psychology
(47)
Technology
(47)
General & Internal Medicine
(44)
Exact Sciences And Technology
(39)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(439)
EZB Electronic Journals Library
(418)
Ingenta
(360)
Journals@OVID
(324)
Publisher website
(285)
Access via ScienceDirect (Elsevier)
(201)
Wiley Online Library
(144)
IngentaConnect Journals
(138)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(117)
Wiley Online Library
(83)
JSTOR
(82)
SpringerLink_现刊
(52)
Oxford journals
(42)
Oxford Journals 2020 Medicine
(37)
IEEE Xplore
(36)
Nexis Uni
(32)
Access via Taylor & Francis
(29)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(27)
Taylor & Francis
(27)
Access via Taylor & Francis
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)